CA-125: an evolving role in the management of ovarian cancer.
Markman
M
M
D000970:Antineoplastic Agents / Q000627:therapeutic use; D018394:CA-125 Antigen / Q000097:blood*; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000097:blood* / Q000188:drug therapy
D000970:Antineoplastic Agents; D018394:CA-125 Antigen